Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Agios Pharmaceuticals (AGIO) Leases (2019 - 2025)

Agios Pharmaceuticals' Leases history spans 7 years, with the latest figure at $30.5 million for Q4 2025.

  • For Q4 2025, Leases fell 28.98% year-over-year to $30.5 million; the TTM value through Dec 2025 reached $30.5 million, down 28.98%, while the annual FY2025 figure was $30.5 million, 28.98% down from the prior year.
  • Leases reached $30.5 million in Q4 2025 per AGIO's latest filing, down from $33.6 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $82.2 million in Q1 2021 to a low of $95000.0 in Q1 2022.
  • Average Leases over 5 years is $46.3 million, with a median of $50.2 million recorded in 2024.
  • Peak YoY movement for Leases: plummeted 99.88% in 2022, then skyrocketed 65711.58% in 2023.
  • A 5-year view of Leases shows it stood at $75.1 million in 2021, then dropped by 13.3% to $65.1 million in 2022, then fell by 16.46% to $54.4 million in 2023, then dropped by 21.19% to $42.9 million in 2024, then fell by 28.98% to $30.5 million in 2025.
  • Per Business Quant, the three most recent readings for AGIO's Leases are $30.5 million (Q4 2025), $33.6 million (Q3 2025), and $36.8 million (Q2 2025).